(Press-News.org) Bethesda, MD—October 1, 2012 – Listed below are the selected highlights for the October 2012 issue of the Genetics Society of America's journal, GENETICS. The October issue is available online at www.genetics.org/content/current. Please credit GENETICS, Vol. 192, October 2012, Copyright © 2012.
Please feel free to forward to colleagues who may be interested in these articles.
ISSUE HIGHLIGHTS
Energy-dependent modulation of glucagon-like signaling in Drosophila via the AMP-activated protein kinase, pp. 457
Jason T. Braco, Emily L. Gillespie, Gregory E. Alberto, Jay E. Brenman, and Erik C. Johnson
How organisms maintain energetic homeostasis is unclear. These authors show that the actions of a known cellular sensor of energy—the AMP-activated protein kinase (AMPK)—cause release of a glucagon-like hormone in Drosophila. They further show that AMPK regulates secretion of adipokinetic hormone. This suggests new roles and targets for AMPK and suggests metabolic networks are organized similarly throughout Metazoa.
The relation of codon bias to tissue-specific gene expression in Arabidopsis thaliana, pp. 641
Salvatore Camiolo, Lorenzo Farina, and Andrea Porceddu
This article reports systematic differences in usage of synonymous codons in Arabidopsis thaliana genes whose expression is tissue specific. The authors propose that codon bias evolves as an adaptive response to the different abundances of tRNAs in different tissues.
Integrity and function of the Saccharomyces cerevisiae spindle pole body depends on connections between the membrane proteins Ndc1, Rtn1, and Yop1, pp. 441
Amanda K. Casey, T. Renee Dawson, Jingjing Chen, Jennifer M. Friederichs, Sue L. Jaspersen, and Susan R. Wente
Budding yeast face an unusual challenge during cell division: they must segregate their chromosomes while the nuclear envelope remains intact. Consequently, mitosis begins with insertion of the duplicated spindle pole body (a.k.a. centrosome) into the nuclear envelope, a process that parallels the generation of new nuclear pore complexes. These authors report data that suggest new mechanisms for linking nuclear division and transport.
Cellular memory of acquired stress resistance in Saccharomyces cerevisiae, pp. 495
Qiaoning Guan, Suraiya Haroon, Diego González Bravo, Jessica L. Will, and Audrey P. Gasch
Cells can retain memory of prior experiences that influence future behaviors. Here, the authors show that budding yeast retains a multifaceted memory of prior stress treatment. Cells pretreated with salt retain peroxide tolerance for several generations after removal of the initial stressor. This is due to long-lived catalase, produced during salt treatment and distributed to daughter cells. These cells also display transcriptional memory dependent on the nuclear pore subunit Nup42 that functions to promote reacquisition of stress tolerance in future stress cycles.
Genomic variation in natural populations of Drosophila melanogaster, pp. 533
Charles H. Langley, Kristian Stevens, Charis Cardeno, Yuh Chwen G. Lee, Daniel R. Schrider, John E. Pool, Sasha A. Langley, Charlyn Suarez, Russell B. Corbett-Detig, Bryan Kolaczkowski, Shu Fang, Phillip M. Nista, Alisha K. Holloway, Andrew D. Kern, Colin N. Dewey, Yun S. Song, Matthew W. Hahn, and David J. Begun
This article greatly extends studies of population genetic variation in natural populations of Drosophila melanogaster, which have played an important role in the development of evolutionary theory. The authors describe genome sequences of 43 individuals taken from two natural populations of D. melanogaster. The genetic polymorphism, divergence, and copy-number variation revealed in these data are presented at several scales, providing unprecedented insight into forces shaping genome polymorphism and divergence.
Estimating allele age and selection coefficient from time-serial data, pp. 599
Anna-Sapfo Malaspinas, Orestis Malaspinas, Steven N. Evans, and Montgomery Slatkin
The relative importance of the four fundamental processes driving evolution—genetic drift, natural selection, migration, and mutation—remains undetermined. These authors propose a new approach to estimate the selection coefficient and the allele age of time serial data. They apply their methodology to ancient sequences of a horse coat color gene and demonstrate that the causative allele existed as a rare segregating variant prior to domestication. This illuminates the debate on the relative importance of new vs. standing variation in adaptation and domestication.
DNA replication origin function is promoted by H3K4 di-methylation in Saccharomyces cerevisiae, pp. 371
Lindsay F. Rizzardi, Elizabeth S. Dorn, Brian D. Strahl, and Jeanette Gowen Cook
What defines a DNA replication origin? It is becoming increasingly apparent that post-translational modifications of nucleosomes near replication origins help mark them and control their activity. The genetic analysis presented in this article implicates di-methylated histone H3 lysine 4 (stimulated by histone H2B monoubiquitination) as part of the definition of active replication origins. Since these histone modifications are highly conserved, these findings are relevant to genome organization in other eukaryotes.
Comparative oncogenomics implicates the Neurofibromin 1 gene (NF1) as a breast cancer driver, pp. 385
Marsha D. Wallace, Adam D. Pfefferle, Lishuang Shen, Adrian J. McNairn, Ethan G. Cerami, Barbara L. Fallon, Vera D. Rinaldi, Teresa L. Southard, Charles M. Perou, and John C. Schimenti
This study of a mouse model of genomic instability indicates that NF1 (Neurofibromin 1) deficiency can drive breast cancer. ~ 63,000 people in the United States annually will develop breast cancer with an NF1 deficiency. Together with evidence that NF1 depletion confers resistance of human breast cancer cells to tamoxifen, these findings suggest therapeutic strategies for patients with NF1-deleted tumors.
###
ABOUT GENETICS: Since 1916, GENETICS has covered high quality, original research on a range of topics bearing on inheritance, including population and evolutionary genetics, complex traits, developmental and behavioral genetics, cellular genetics, gene expression, genome integrity and transmission, and genome and systems biology. GENETICS, a peer-reviewed, peer-edited journal of the Genetics Society of America is one of the world's most cited journals in genetics and heredity.
ABOUT GSA: Founded in 1931, the Genetics Society of America (GSA) is the professional membership organization for scientific researchers, educators, bioengineers, bioinformaticians and others interested in the field of genetics. Its nearly 5,000 members work to advance knowledge in the basic mechanisms of inheritance, from the molecular to the population level. GSA is dedicated to promoting research in genetics and to facilitating communication among geneticists worldwide through its conferences, including the biennial conference on Model Organisms to Human Biology, an interdisciplinary meeting on current and cutting edge topics in genetics research, as well as annual and biennial meetings that focus on the genetics of particular organisms, including C. elegans, Drosophila, fungi, mice, yeast, and zebrafish. GSA publishes GENETICS, a leading journal in the field and an online, open-access journal, G3: Genes|Genomes|Genetics. For more information about GSA, please visit www.genetics-gsa.org. Also follow GSA on Facebook at facebook.com/GeneticsGSA and on Twitter @GeneticsGSA.
Genetics Society of America's GENETICS journal highlights for October 2012
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Evolutionary analysis improves ability to predict the spread of flu
2012-10-01
BETHESDA, MD – October 1, 2012 – With flu season around the corner, getting a seasonal vaccine might be one of the best ways to prevent people from getting sick. These vaccines only work, however, if their developers have accurately predicted which strains of the virus are likely to be active in the coming season because vaccines must be developed in advance of the upcoming flu season. Recently, a team of scientists from Germany and the United Kingdom have improved the prediction methods used to determine which strains of the flu virus to include in the current season's ...
First large scale trial of whole-genome cancer testing for clinical decision-making reported
2012-10-01
VIENNA, Austria, 1 October 2012 – For the first time, researchers have conducted a large trial in which they tested the entire genome of individual breast cancers to help personalize treatment. They released their findings at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
In recent years, a number of drugs have been developed that target specific genetic alterations in cancer. To choose which of these drugs are suitable for individual patients, some genetic testing is performed. "In most of these cases, these genetic testing approaches ...
New findings on optimal duration of trastuzumab therapy for women with HER2+ early breast cancer
2012-10-01
VIENNA, Austria, 1 October 2012 – New studies that advance understanding of the optimal duration of therapy with the targeted cancer drug trastuzumab were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
"These long awaited results constitute a further milestone in the treatment of patients with early breast cancer over-expressing HER2/neu, corresponding to a population of about 12-15% of all cases of breast cancer," commented Prof Christoph Zielinski, Chairman of the Clinical Division of Oncology, at Medical University ...
Phase III data in treatment of renal cell carcinoma reported
2012-10-01
Vienna, Austria, 1 October 2012 – New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Renal cell carcinoma is a type of kidney cancer that starts in the lining of very small tubes (tubules) in the kidney.
Prof Maria De Santis from Kaiser Franz Josef-Spital, Vienna, Chair of the ESMO 2012 Genitourinary program track (who was not involved in the studies) commented: "At this year's ESMO congress, three urgently awaited ...
New findings highlight the challenges of managing blood clotting in cancer patients
2012-10-01
VIENNA, Austria, 1 October 2012 – New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Venous thromboembolism causes symptoms in about 3 to 4% of cancer patients whose chemotherapy drugs are delivered via a central venous catheter, comments Dr. Fausto Roila, from Medical Oncology Department, Terni, Italy, Chair of the ESMO 2012 Supportive Care Track. "When asymptomatic patients are considered, these events affect ...
Should aspirin be used to prevent cancer?
2012-10-01
VIENNA, Austria, 1 October 2012 – Aspirin, the everyday drug taken by countless people around the world to ward off pain and reduce their risk of developing heart disease, may have a new trick up its sleeve –-preventing cancer.
A growing body of evidence suggests that taking aspirin may reduce an individual's chances of developing colorectal cancer and perhaps other malignancies, but whether that evidence is strong enough to outweigh the risks of prescribing it to millions of healthy people is the subject of debate.
At the ESMO 2012 Congress in Vienna, both sides of ...
Putting a 'HEX' on muscle regeneration
2012-10-01
A complex genetic regulatory network mediates the regeneration of adult skeletal muscles. In this issue of the Journal of Clinical Investigation, researchers at the State University of New York Downstate Medical Center in Brooklyn report that HEXIM1, a protein that regulates gene transcription, is important for skeletal muscle regeneration in mice. M.A.Q. Saddiqui and colleagues found that HEXIM1 blocks gene expression that is required for muscle regeneration after injury. Mice with a 50% reduction in HEXIM1 exhibited greater muscle mass and function after injury compared ...
JCI early table of contents for October 1, 2012
2012-10-01
Sphingolipid metabolism contributes to diabetes-associated heart disease
Patients with type 2 diabetes are subject to a number of major health risks, including a greatly increased risk of heart failure. This is due in part to the development of diabetic cardiomyopathy (DbCM), a condition that significantly impairs heart function. In this issue of the Journal of Clinical Investigation, Ashley Cowart and colleagues at the Medical University of South Carolina report that an increase in specific types of saturated fatty acids (SFAs) and fatty acid metabolic pathways cause ...
Public health messages can influence infectious disease stigmas
2012-10-01
UNIVERSITY PARK, Pa. -- Crafting public health messages about a disease may create stigmas that influence how likely people are to endorse certain interventions, such as isolating infected persons, forcing treatment on them and mapping their location, according to a Penn State researcher.
Rachel Smith, associate professor of communication arts and sciences and investigator with the University's Center for Infectious Disease Dynamics, used a hypothetical disease -- a virus carried by rodents -- to develop 16 different health alerts describing the virus and those who were ...
Preoperative needle breast biopsies can lead to improved treatment outcomes
2012-10-01
Chicago: Women suspected of having breast cancer now have more reasons to be diagnosed with a needle biopsy instead of a traditional open surgical biopsy. Besides avoiding the risks and discomfort of an open surgical procedure, needle biopsies can also lead to improved treatment outcomes according to findings from a new study published in the October issue of the Journal of the American College of Surgeons.
Breast cancer is the number one form of cancer diagnosed in women in the United States, according to the U.S. Centers for Disease Control and Prevention. [1] In ...